Annual EBIT
-$214.05 M
-$84.91 M-65.75%
December 31, 2023
Summary
- As of February 8, 2025, XENE annual earnings before interest & taxes is -$214.05 million, with the most recent change of -$84.91 million (-65.75%) on December 31, 2023.
- During the last 3 years, XENE annual EBIT has fallen by -$185.44 million (-648.18%).
- XENE annual EBIT is now -1869.63% below its all-time high of $12.10 million, reached on December 31, 2013.
Performance
XENE EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$73.68 M
-$4.57 M-6.62%
September 30, 2024
Summary
- As of February 8, 2025, XENE quarterly earnings before interest & taxes is -$73.68 million, with the most recent change of -$4.57 million (-6.62%) on September 30, 2024.
- Over the past year, XENE quarterly EBIT has dropped by -$4.57 million (-6.62%).
- XENE quarterly EBIT is now -950.66% below its all-time high of $8.66 million, reached on September 30, 2014.
Performance
XENE Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$255.52 M
-$17.99 M-7.57%
September 30, 2024
Summary
- As of February 8, 2025, XENE TTM earnings before interest & taxes is -$255.52 million, with the most recent change of -$17.99 million (-7.57%) on September 30, 2024.
- Over the past year, XENE TTM EBIT has dropped by -$17.99 million (-7.57%).
- XENE TTM EBIT is now -1979.76% below its all-time high of $13.59 million, reached on September 30, 2014.
Performance
XENE TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
XENE EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -65.8% | -6.6% | -7.6% |
| 3 y3 years | -648.2% | -32.5% | -37.3% |
| 5 y5 years | -546.2% | -32.5% | -37.3% |
XENE EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -171.0% | at low | -324.2% | at low | -223.5% | at low |
| 5 y | 5-year | -648.2% | at low | <-9999.0% | at low | -854.1% | at low |
| alltime | all time | -1869.6% | at low | -950.7% | at low | -1979.8% | at low |
Xenon Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$73.68 M(+6.6%) | -$255.52 M(+7.6%) |
| Jun 2024 | - | -$69.10 M(+17.0%) | -$237.52 M(+6.0%) |
| Mar 2024 | - | -$59.04 M(+10.0%) | -$224.04 M(+4.7%) |
| Dec 2023 | -$214.05 M(+65.7%) | -$53.70 M(-3.6%) | -$214.05 M(+5.1%) |
| Sep 2023 | - | -$55.68 M(+0.1%) | -$203.69 M(+9.4%) |
| Jun 2023 | - | -$55.62 M(+13.4%) | -$186.13 M(+15.7%) |
| Mar 2023 | - | -$49.05 M(+13.2%) | -$160.82 M(+24.5%) |
| Dec 2022 | -$129.14 M(+63.5%) | -$43.33 M(+13.6%) | -$129.14 M(+16.7%) |
| Sep 2022 | - | -$38.13 M(+25.8%) | -$110.65 M(+25.6%) |
| Jun 2022 | - | -$30.32 M(+74.5%) | -$88.12 M(+9.7%) |
| Mar 2022 | - | -$17.37 M(-30.1%) | -$80.30 M(+1.7%) |
| Dec 2021 | -$78.99 M(+176.1%) | -$24.84 M(+59.2%) | -$78.99 M(+18.8%) |
| Sep 2021 | - | -$15.60 M(-30.7%) | -$66.49 M(+10.9%) |
| Jun 2021 | - | -$22.50 M(+40.1%) | -$59.95 M(+59.8%) |
| Mar 2021 | - | -$16.06 M(+30.2%) | -$37.51 M(+31.1%) |
| Dec 2020 | -$28.61 M(-28.8%) | -$12.34 M(+36.2%) | -$28.61 M(+4.7%) |
| Sep 2020 | - | -$9.06 M(>+9900.0%) | -$27.34 M(+2.1%) |
| Jun 2020 | - | -$60.00 K(-99.2%) | -$26.78 M(-26.4%) |
| Mar 2020 | - | -$7.16 M(-35.3%) | -$36.39 M(-9.4%) |
| Dec 2019 | -$40.18 M(+21.3%) | -$11.06 M(+30.1%) | -$40.18 M(+7.6%) |
| Sep 2019 | - | -$8.50 M(-12.1%) | -$37.34 M(-12.2%) |
| Jun 2019 | - | -$9.67 M(-11.6%) | -$42.55 M(+5.1%) |
| Mar 2019 | - | -$10.95 M(+33.1%) | -$40.49 M(+22.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$33.13 M(+7.9%) | -$8.22 M(-40.0%) | -$33.13 M(+0.5%) |
| Sep 2018 | - | -$13.71 M(+80.2%) | -$32.97 M(+22.1%) |
| Jun 2018 | - | -$7.61 M(+112.3%) | -$27.00 M(-1.0%) |
| Mar 2018 | - | -$3.58 M(-55.6%) | -$27.28 M(-13.9%) |
| Dec 2017 | -$30.70 M(+23.7%) | -$8.06 M(+4.2%) | -$31.69 M(+8.9%) |
| Sep 2017 | - | -$7.74 M(-1.9%) | -$29.08 M(+1.4%) |
| Jun 2017 | - | -$7.89 M(-1.2%) | -$28.67 M(+5.6%) |
| Mar 2017 | - | -$7.99 M(+46.2%) | -$27.15 M(+9.4%) |
| Dec 2016 | -$24.82 M(+165.1%) | -$5.46 M(-25.5%) | -$24.82 M(+13.0%) |
| Sep 2016 | - | -$7.33 M(+15.2%) | -$21.96 M(+42.2%) |
| Jun 2016 | - | -$6.37 M(+12.5%) | -$15.45 M(+73.9%) |
| Mar 2016 | - | -$5.66 M(+117.4%) | -$8.88 M(-5.1%) |
| Dec 2015 | -$9.36 M(-184.3%) | -$2.60 M(+217.4%) | -$9.36 M(+39.2%) |
| Sep 2015 | - | -$820.00 K(-512.1%) | -$6.72 M(-343.8%) |
| Jun 2015 | - | $199.00 K(-103.2%) | $2.76 M(-29.9%) |
| Mar 2015 | - | -$6.14 M(<-9900.0%) | $3.94 M(-64.6%) |
| Dec 2014 | $11.11 M(-8.2%) | $35.00 K(-99.6%) | $11.11 M(-18.3%) |
| Sep 2014 | - | $8.66 M(+528.5%) | $13.59 M(+20.0%) |
| Jun 2014 | - | $1.38 M(+33.5%) | $11.32 M(+13.9%) |
| Mar 2014 | - | $1.03 M(-59.1%) | $9.95 M(+11.6%) |
| Dec 2013 | $12.10 M(-387.5%) | $2.52 M(-60.6%) | $8.91 M(+39.4%) |
| Sep 2013 | - | $6.39 M | $6.39 M |
| Dec 2012 | -$4.21 M(-64.6%) | - | - |
| Dec 2011 | -$11.90 M | - | - |
FAQ
- What is Xenon Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals annual EBIT year-on-year change?
- What is Xenon Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals quarterly EBIT year-on-year change?
- What is Xenon Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals TTM EBIT year-on-year change?
What is Xenon Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of XENE is -$214.05 M
What is the all time high annual EBIT for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual earnings before interest & taxes is $12.10 M
What is Xenon Pharmaceuticals annual EBIT year-on-year change?
Over the past year, XENE annual earnings before interest & taxes has changed by -$84.91 M (-65.75%)
What is Xenon Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of XENE is -$73.68 M
What is the all time high quarterly EBIT for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly earnings before interest & taxes is $8.66 M
What is Xenon Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, XENE quarterly earnings before interest & taxes has changed by -$4.57 M (-6.62%)
What is Xenon Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of XENE is -$255.52 M
What is the all time high TTM EBIT for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high TTM earnings before interest & taxes is $13.59 M
What is Xenon Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, XENE TTM earnings before interest & taxes has changed by -$17.99 M (-7.57%)